Comparator: metronidazole / Duration of Treatment: 8 Weeks

DRUG2 trials

Sponsors

Merck Sharp & Dohme LLC, MERCK SHARP & DOHME PERU S.R.L.,

Conditions

Intra-abdominal Infection

Phase 3

A Study to Evaluate the Safety and Effectiveness of Ertapenem Versus Ceftriaxone/Metronidazole in the Treatment of Intra-abdominal Infections in Adults (0826-802)

CompletedNCT00481702

Merck Sharp & Dohme LLCIntra-abdominal Infection

Start: 2001-12-31End: 2003-06-30Target: 300Updated: 2017-02-20

Unknown Phase

A Prospective, Multicenter, Open-Label, Randomized, Comparative Study to Evaluate the Efficacy, Safety, and Tolerability of Ertapenem Versus Ceftriaxone/Metronidazole in the Treatment of Intra-Abdominal Infections in Adults

Active, not recruitingPER-063-01

MERCK SHARP & DOHME PERU S.R.L.,

Target: 23Updated: 2023-09-04